Temolina-M is a combination oral antidiabetic medicine used for the management of type 2 diabetes mellitus in adults. It combines complementary mechanisms to improve glycemic control by enhancing insulin secretion, reducing hepatic glucose production, and improving the body’s response to insulin. This dual-action approach helps maintain stable blood glucose levels throughout the day and supports comprehensive diabetes management when lifestyle modifications alone are insufficient. Temolina-M is commonly prescribed for patients requiring combination therapy to achieve better metabolic control and reduce the risk of diabetes-related complications affecting the heart, kidneys, nerves, and eyes. By supporting long-term blood sugar regulation, Temolina-M contributes to improved overall health outcomes and enhanced quality of life for individuals living with type 2 diabetes.